EQT Foundation
Breakthrough Startups
From the EQT Foundation Fund, we invest in solutions with the potential for meaningful impact within climate & nature and health & wellbeing, focusing on transformative innovations with strong potential to scale. Our investments provide catalytic capital to early-stage companies tackling systemic challenges, helping them bridge critical funding gaps and accelerate their path to market.
The EQT Foundation fund
The EQT Foundation Fund is an evergreen investment vehicle designed to support deep science and pioneering technology with patient, flexible capital. Unlike traditional funds, it operates without fixed timelines, allowing long-term engagement with ventures that require extended development cycles.
Structured as a Swedish investment company, it is controlled by Stiftelsen EQT Foundation and capitalized by its Members, who are senior Partners at EQT or Alumni. The Fund invests in solutions that align with EQT’s thematic expertise, providing not only capital but also strategic insights, industry networks, and scaling support.
Investment focus and due diligence
In climate and nature, we prioritize technologies that contribute to Net Zero by 2050 or significantly reduce biodiversity loss. In health and wellbeing, we seek innovations that either reach large underserved populations or deeply impact specific medical challenges, with a strong focus on deep tech solutions.
Each investment undergoes rigorous due diligence, assessing impact potential, technological novelty, business model viability, scalability, and risk factors. Instead of relying solely on financial metrics, we track companies through milestone-based progress assessments.
Climate investments are guided by The Climate Brick, a structured manual for scaling climate tech solutions, while health investments are evaluated through tailored frameworks informed by EQT Life Sciences expertise.
Beyond capital: how we support founders
The EQT Foundation Fund provides strategic support, industry expertise, and access to the EQT network. We match portfolio companies with dedicated deal teams comprising EQT professionals with sector-specific knowledge. These teams work closely with founders to navigate scaling challenges, refine strategies, and secure key partnerships.
Our companies also benefit from the global EQT network, including over 500 Industrial Advisors and 300+ EQT portfolio companies, offering valuable connections and mentorship. By combining capital, expertise, and strategic partnerships, we help climate and health innovators turn bold ideas into market ready solutions that can potentially drive meaningful change.
Climate & Nature
We invest in breakthrough innovations that protect and regenerate our planet. From decarbonization to biodiversity, we focus on solutions that address root causes, not symptoms. This means backing bold technologies that accelerate the energy transition, enable circular and regenerative systems, and help restore ecosystems at scale.
Current approaches for harnessing rare metals are energy-intensive and environmentally damaging. Emerging technologies are exploring cheaper, more efficient alternatives, including novel approaches to producing synthetic or substitute materials. Artificial intelligence (AI) is also playing a critical role in this shift, enabling faster material discovery, precise modeling, and accelerated experimentation. By reducing development time and cost of experimentation, AI-driven innovation in nanomaterials could unlock a more scalable, accessible green transition.
Health & Wellbeing
Tissue Engineering: Building the Future of Medicine
Tissue therapeutics is a rapidly developing field with the potential to transform regenerative medicine, offering curative treatments for chronic diseases and addressing the limitations of traditional transplants. By leveraging bioengineered tissues and advanced laboratory techniques, scientists are developing functional replacements for damaged organs and tissues, creating alternatives that are more accessible and scalable than donor-based solutions.
We support science-driven innovations that improve health outcomes and quality of life, especially for underserved communities. Our focus spans early detection, precision prevention, and equitable access to care, always seeking catalytic ideas that shift healthcare from reactive to proactive, and empower individuals to live longer, healthier lives.
As tissue engineering matures, its applications are extending beyond regenerative medicine into areas that could shift healthcare from disease management to prevention, and even reversal, offering a new frontier in how we approach human health.
Featured Investments
See all
Financial transparency for families
Charly is a fintech company dedicated to creating greater financial equality for families. They support families in identifying financial gaps throughout their journey of building a family and provide a tailored solution with their Family Equality Insurance. This innovative insurance bridges financial shortfalls until retirement, managed through a portfolio of sustainable funds, with benefits paid out at retirement or during significant life events like divorce.
Health and Wellbeing
Founders
Lisa Malmrose
Alexandra Karnig
EQT Deal Team
Country
Sweden
Revolutionizing tissue regeneration
ClexBio is a biotechnology company developing next-generation tissue therapies to address chronic diseases, starting with liver disease. Their platform combines three cell types to create functional tissue structures that closely mimic human biology, offering new hope for patients with limited treatment options. By improving the effectiveness and longevity of tissue therapies, ClexBio aims to transform regenerative medicine and treatment for chronic conditions.
Health and Wellbeing
Founder
Armend Håti
EQT Deal Team
Country
Switzerland
Diagnose infections quickly, accurately, and affordably
The ability to diagnose viral and bacterial infections quickly, accurately, and at low cost is crucial in order to provide the right treatment early and to prevent the spread of infectious diseases and antibiotic resistance. VIDEM has developed a patented technology to diagnose infections in care settings or in the home, with accurate results in less than an hour.
Health and Wellbeing
Founders
EQT Deal Team
Country
Sweden
Equitable reproductive benefits in the UK and Europe
Fertifa offers UK and European employers a platform for expert clinical advice and financial support in fertility and reproductive health. Their services help employees access care and reduce stigma, while educational programs promote a supportive and inclusive workplace.
Health and Wellbeing
Founders
Tony Chen
Nick Kuan
EQT Deal Team
Nazanine Metghalchi
Country
UK
New carbon-negative technologies
Patch has developed an API and a portfolio approach to carbon offsets that allow carbon offset purchasers to choose a higher average price and diversify among carbon offset projects, supporting the development of new negative-carbon technologies.
Climate and Nature
Founder
EQT Deal Team
Country
USA